{
    "eid": "2-s2.0-84931571793",
    "title": "EGFR mutation testing practices within the Asia pacific region: Results of a multicenter diagnostic survey",
    "cover-date": "2015-03-30",
    "subject-areas": [
        {
            "$": "Oncology",
            "@code": "2730"
        },
        {
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740"
        }
    ],
    "keywords": [
        "EGFR mutation",
        "Multicenter",
        "Non-small-cell lung cancer",
        "Survey",
        "Testing"
    ],
    "authors": [
        "Yasushi Yatabe"
    ],
    "citedby-count": 159,
    "ref-count": 19,
    "ref-list": [
        "Mutation incidence and coincidence in non small-cell lung cancer: Meta-analyses by ethnicity and histology (mutMap)",
        "GLOBOCAN (IARC) 2012. Lung Cancer Fact Sheet",
        "Somatic mutations affect key pathways in lung adenocarcinoma",
        "New driver mutations in non-small-cell lung cancer",
        "Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma",
        "Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer",
        "J Thorac Oncol",
        "Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR",
        "Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial",
        "Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial",
        "Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study",
        "Recommendations for mutational analysis of ECFR in lung carcinoma",
        "Consensus for EGFR mutation testing in non-small cell lung cancer: Results from a European workshop",
        "National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China",
        "The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers",
        "Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer",
        "EGFR mutation testing in lung cancer: A review of available methods and their use for analysis of tumour tissue and cytology samples",
        "Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the study of lung cancer, and Association for Molecular Pathology",
        "An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting"
    ],
    "affiliation": [
        {
            "affiliation-city": "Taipei",
            "affilname": "Taipei Veterans General Hospital",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Cambridge",
            "affilname": "AstraZeneca",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Okayama",
            "affilname": "Graduate School of Medicine, Dentistry and Pharmaceutical Sciences",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Shanghai",
            "affilname": "Fudan University Shanghai Cancer Center",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Seongnam",
            "affilname": "Seoul National University Bundang Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Guangzhou",
            "affilname": "Sun Yat-Sen University Cancer Center",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Quezon City",
            "affilname": "St. Luke's Medical Center Quezon City",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Manila",
            "affilname": "De La Salle University",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Hanoi",
            "affilname": "Hanoi Medical University",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Goyang",
            "affilname": "National Cancer Center, Gyeonggi",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Nagoya",
            "affilname": "Aichi Cancer Center Hospital and Research Institute",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "University of Melbourne",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Moroyama",
            "affilname": "Saitama Medical University",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bandar Sunway",
            "affilname": "Monash University Malaysia",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Singapore City",
            "affilname": "Singapore General Hospital",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Naples",
            "affilname": "Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Aberdeen",
            "affilname": "University of Aberdeen School of Medicine, Medical Sciences and Nutrition",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Beijing",
            "affilname": "Peking Union Medical College Hospital",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Sungkyunkwan University",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "Chinese University of Hong Kong",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Jakarta",
            "affilname": "Stem Cell and Cancer Institute",
            "affiliation-country": "Indonesia"
        }
    ],
    "funding": [
        "Applied Biomathematics Inc.",
        "AstraZeneca",
        "Roche",
        "State University of New York",
        "Japan Society for the Promotion of Science"
    ]
}